Fate Therapeutics, Inc.
NASDAQ:FATEBiotechnology
Healthcare
$1.05 -0.00%
-$0.00 today
- Market cap
- $122.39M
- Beta
- 2.52
- P/E (TTM)
- -1.8
- EPS (TTM)
- -$1.08
52W Low $0.91High $2.88
Volume 1.87M
Average 2.92M
Price history
Fate Therapeutics, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
+0.00%
Period high
$3.11
Period low
$0.98
Latest
$1.05
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| 424B5 | Nov 12, 2026 | Nov 12, 2026 | |
| EFFECT | Nov 12, 2026 | Nov 13, 2026 | |
| SC 13D/A | Nov 9, 2026 | Nov 9, 2026 | |
| 8-K | Nov 5, 2026 | Nov 5, 2026 | |
| S-3 | Nov 5, 2026 | Nov 5, 2026 | |
| 424B5 | Nov 5, 2026 | Nov 5, 2026 | |
| 8-K | Nov 5, 2026 | Nov 5, 2026 | |
| 10-Q | Nov 5, 2026 | Nov 5, 2026 | |
| 4 | Nov 4, 2026 | Nov 4, 2026 | |
| 8-K | Sep 28, 2026 | Sep 28, 2026 | |
| 10-Q | Aug 13, 2026 | Aug 13, 2026 | |
| 8-K | Aug 13, 2026 | Aug 13, 2026 | |
| S-8 | Aug 13, 2026 | Aug 13, 2026 | |
| 4 | Aug 5, 2026 | Aug 5, 2026 | |
| 4 | Aug 5, 2026 | Aug 5, 2026 |
Competitors
Who does Fate Therapeutics, Inc. compete with?
Open similar companies to compare their filings and price history.
Questions
Filing questions
Common questions about FATE's filings, answered from its disclosures.
What is the latest FATE filing?
The latest filing shown is EFFECT dated Nov 12, 2026.
How many recent filings does FATE have?
Intrinsic Alpha currently shows 20 recent filings for FATE.
Continue the stock analysis
Jump to another research area for this company.